Vir Biotechnology, Inc. VIR Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s accrued expenses?
- Vir Biotechnology, Inc. (VIR) reported accrued expenses of $68.11M in Q1 2026.
- How has Vir Biotechnology, Inc.'s accrued expenses changed year-over-year?
- Vir Biotechnology, Inc.'s accrued expenses decreased by 34.6% year-over-year, from $104.13M to $68.11M.
- What is the long-term trend for Vir Biotechnology, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s accrued expenses has grown at a 1.5% compound annual growth rate (CAGR), from $76.94M to $83.01M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.